TherapeuticsMD, Inc. (TXMD) Free cash flow 2016–2022
TherapeuticsMD, Inc. (TXMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$9.3MFY2022 · since FY2016: -$69.3M → $9.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $9.3M | +106.5% |
| FY2021 | -$142.9M | +11.7% |
| FY2020 | -$161.9M | +2.4% |
| FY2019 | -$165.9M | -55.3% |
| FY2018 | -$106.9M | -39.6% |
| FY2017 | -$76.6M | -10.5% |
| FY2016 | -$69.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice